Phase 2 Trial of Glasdegib in Myelofibrosis Was Not Launched - Due to modest overall response in clinical activity

Phase 2 Trial of Glasdegib in Myelofibrosis Was Not Launched - Due to modest overall response in clinical activity

User Photo
ASHReport

2 years
167 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aaron Gerds, MD from Cleveland Clinics discusses Phase 2 Trial of Glasdegib in myelofibrosis was not launched - due to modest overall response in clinical activity at the 2017 American Society of Hematology.
Up Next Autoplay